Caxton Associates LLP Ani Pharmaceuticals Inc Transaction History
Caxton Associates LLP
- $4.11 Billion
- Q3 2025
A detailed history of Caxton Associates LLP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Caxton Associates LLP holds 37,848 shares of ANIP stock, worth $3.18 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
37,848Holding current value
$3.18 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
285Shares Held
20.3MCall Options Held
30.6KPut Options Held
30.7K-
Black Rock Inc. New York, NY2.66MShares$223 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$107 Million0.0% of portfolio
-
State Street Corp Boston, MA712KShares$59.8 Million0.0% of portfolio
-
Global Alpha Capital Management Ltd.631KShares$53 Million3.26% of portfolio
-
Ubs Group Ag590KShares$49.6 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.46B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...